Filter News
Area of Research
News Topics
- (-) Artificial Intelligence (1)
- (-) Bioenergy (1)
- (-) Biomedical (1)
- (-) Machine Learning (1)
- (-) Physics (2)
- Biology (2)
- Clean Water (1)
- Computer Science (3)
- Cybersecurity (1)
- Decarbonization (1)
- Energy Storage (4)
- Environment (4)
- Frontier (1)
- Materials (3)
- Materials Science (3)
- National Security (1)
- Neutron Science (18)
- Nuclear Energy (1)
- Quantum Science (1)
- Security (1)
- Space Exploration (1)
- Summit (1)
Media Contacts
While studying how bio-inspired materials might inform the design of next-generation computers, scientists at ORNL achieved a first-of-its-kind result that could have big implications for both edge computing and human health.
To solve a long-standing puzzle about how long a neutron can “live” outside an atomic nucleus, physicists entertained a wild but testable theory positing the existence of a right-handed version of our left-handed universe.
Illustration of the optimized zeolite catalyst, or NbAlS-1, which enables a highly efficient chemical reaction to create butene, a renewable source of energy, without expending high amounts of energy for the conversion. Credit: Jill Hemman, Oak Ridge National Laboratory/U.S. Dept. of Energy
ORNL computer scientist Catherine Schuman returned to her alma mater, Harriman High School, to lead Hour of Code activities and talk to students about her job as a researcher.
An ORNL-led team's observation of certain crystalline ice phases challenges accepted theories about super-cooled water and non-crystalline ice. Their findings, reported in the journal Nature, will also lead to better understanding of ice and its various phases found on other planets, moons and elsewhere in space.
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.